Carbohydrate key to C. diff vaccine

German researchers have synthesized a carbohydrate on the surface of an extremely virulent strain of Clostridium difficile, a potentially deadly hospital-acquired infection, that could lead to a vaccine for the difficult-to-treat disease. Max Planck Institute scientists hope that they can develop a vaccine based on the carbohydrate that enables the body to recognize and respond to the threat of infection. Article